Browsing by Author "Webb, Joseph P."

Now showing 1 - 2 of 2
  • Thumbnail Image
    ItemOpen Access
    From formulation to in vivo model: A comprehensive study of a synergistic relationship between vancomycin, carvacrol and cuminaldehyde against Enterococcus faecium
    (Wiley, 2020-02-11) Owen, Lucy; Webb, Joseph P.; Green, Jeffrey; Smith, Laura J.; Laird, Katie
    Vancomycin Resistant Enterococcus faecium (VRE) has become endemic in healthcare settings, reducing treatment options for enterococcal infections. New antimicrobials for VRE infections are a high priority, but the development of novel antibiotics is time-consuming and expensive. Essential Oils (EOs) synergistically enhance the activity of some existing antibiotics, suggesting that EO-antibiotic combinations could re-sensitise resistant bacteria and maintain the antibiotic repertoire. The mechanism of re-sensitisation of bacteria to antibiotics by EOs is relatively understudied. Here, the synergistic interactions between carvacrol (1.98 mM) and cuminaldehyde (4.20 mM) were shown to re-establish susceptibility to vancomycin (0.031 mg/L) in VRE, resulting in bactericidal activity (4.73 log10 CFU/mL reduction). Gene expression profiling, coupled with β-galactosidase leakage and salt tolerance assays suggested that cell envelope damage contributes to the synergistic bactericidal effect against VRE. The EO-vancomycin combination was also shown to kill clinical isolates of VRE (2.33-5.25 log10 CFU/mL reduction) and stable resistance did not appear to develop even after multiple passages. The in vivo efficacy of the EO-vancomycin combination was tested in a Galleria mellonella larvae assay; however no antimicrobial action was observed, indicating that further drug development is required for the EO-vancomycin combination to be clinically useful for treatment of VRE infections.
  • No Thumbnail Available
    ItemMetadata only
    Transcriptional response of vancomycin resistant Enterococcus faecium to a synergistic antibiotic-essential oil combination: A strategy to preserve the current antibiotic repertoire?
    (2019-04) Owen, Lucy; Webb, Joseph P.; Green, Jeffrey; Smith, Laura J.; Laird, Katie
    Background: New antimicrobials to treat Vancomycin Resistant Enterococcus faecium (VRE) infections are considered a high priority. Essential oil compounds have been shown to interact synergistically with antibiotics, and so could be used as adjuvants to preserve the antibiotic repertoire. A combination of carvacrol, cuminaldehyde and vancomycin was found to synergistically inhibit VRE, potentially extending the utility of vancomycin against VRE. This study aimed to investigate the mechanism of action of the carvacrol, cuminaldehyde and vancomycin combination against VRE using transcriptomic analysis. Materials/methods: The antimicrobial activity of the combination in 1% DMSO was determined by a time-kill assay. Transcriptomic response of VRE to the combination was determined by microarray analysis. VRE was treated with either 0.031 mg/L vancomycin, 1.98 mM carvacrol, 4.20 mM cuminaldehyde or the ternary combination for 60 minutes. A control of 1% DMSO only was included. RNA was extracted, converted to cDNA labelled with Cy5 and hybridised onto a custom microarray and scanned. Significant (p<0.05) differences in gene expression were determined using a one-way Analysis of Variance (ANOVA) with Benjamini Hochberg FDR multiple testing correction and Tukey’s post-hoc test. Expression changes of genes of interest were confirmed by real time quantitative PCR. Results: The combination of carvacrol, cuminaldehyde and vancomycin reduced VRE by 3.96 log10 Colony Forming Units/mL over 24 hours. Expression of 14 genes were significantly altered by the combination (p<0.05, >2-fold change). Genes with the greatest change in expression mainly related to carbohydrate metabolism; the phosphotransferase system (PTS)-associated genes mtlD, mtlF and agaC6 were downregulated 2.86-2.28-fold and ulaA3 was upregulated 4.07-fold. Glutamine-fructose-6-phosphate aminotransferase (glmS), which is associated with amino sugar biosynthesis was downregulated 2.67-3.83-fold. Vancomycin resistance-associated genes were not altered by the combination or individual components. Conclusions: Carvacrol and cuminaldehyde synergistically enhance the antimicrobial activity of vancomycin against VRE, and so could be useful to preserve the antibiotic repertoire. The combination affected carbohydrate metabolism and biosynthetic processes, indicating that the combination did not directly modulate antibiotic resistance genes. Further research will investigate significantly changed genes to enhance understanding of the synergistic mechanism of action of the combination.